|
|
||||||||
Published online before print September 19, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RI signals
,#,1



,
,3
* Department of Pathology, Stanford University School of Medicine, Stanford, California, USA;
# Department of Dental Anesthesiology, Tokyo Dental College, Chiba, Japan;
Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, Japan;
Division of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University Graduate School of Medical Sciences, Tokyo, Japan;
Atopy Research Center, Juntendo University, Tokyo, Japan;
|| Department of Respiratory Medicine, National Disaster Medical Center of Japan, Tokyo, Japan; and
¶ Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan
2Correspondence: Department of Pathology, L-235, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5324, USA. E-mail: sgalli{at}stanford.edu
The IL-1-related molecules, IL-1 and IL-18, can promote Th2 cytokine production by IgE/antigen-Fc
RI-stimulated mouse mast cells. Another IL-1-related molecule, IL-33, was identified recently as a ligand for T1/ST2. Although mouse mast cells constitutively express ST2, the effects of IL-33 on mast cell function are poorly understood. We found that IL-33, but not IL-1β or IL-18, induced IL-13 and IL-6 production by mouse bone marrow-derived, cultured mast cells (BMCMCs) independently of IgE. In BMCMCs incubated with the potently cytokinergic SPE-7 IgE without specific antigen, IL-33, IL-1β, and IL-18 each promoted IL-13 and IL-6 production, but the effects of IL-33 were more potent than those of IL-1β or IL-18. IL-33 promoted cytokine production via a MyD88-dependent but Toll/IL-1R domain-containing adaptor-inducing IFN-β-independent pathway. By contrast, IL-33 neither induced nor enhanced mast cell degranulation. At 200 ng/ml, IL-33 prolonged mast cell survival in the absence of IgE and impaired survival in the presence of SPE-7 IgE, whereas at 100 ng/ml, IL-33 had no effect on mast cell survival in the absence of IgE and reduced mast cell survival in the presence of IgE. These observations suggest potential roles for IL-33 in mast cell- and Th2 cytokine-associated immune responses and disorders.
Key Words: cytokines Fc receptors mast cells/basophils allergy
This article has been cited by other articles:
![]() |
Z. Wiener, P. Pocza, M. Racz, G. Nagy, G. Tolgyesi, V. Molnar, J. Jaeger, E. Buzas, E. Gorbe, Z. Papp, et al. IL-18 induces a marked gene expression profile change and increased Ccl1 (I-309) production in mouse mucosal mast cell homologs Int. Immunol., October 21, 2008; (2008) dxn115v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kurowska-Stolarska, P. Kewin, G. Murphy, R. C. Russo, B. Stolarski, C. C. Garcia, M. Komai-Koma, N. Pitman, Y. Li, A. N. J. McKenzie, et al. IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4 J. Immunol., October 1, 2008; 181(7): 4780 - 4790. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kuchler, J. Pollheimer, J. Balogh, J. Sponheim, L. Manley, D. R. Sorensen, P. M. De Angelis, H. Scott, and G. Haraldsen Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation Am. J. Pathol., October 1, 2008; 173(4): 1229 - 1242. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hudson, G. P. Christophi, R. C. Gruber, J. R. Wilmore, D. A. Lawrence, and P. T. Massa Induction of IL-33 expression and activity in central nervous system glia J. Leukoc. Biol., September 1, 2008; 84(3): 631 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, H.-R. Jiang, P. Kewin, Y. Li, R. Mu, A. R. Fraser, N. Pitman, M. Kurowska-Stolarska, A. N. J. McKenzie, I. B. McInnes, et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells PNAS, August 5, 2008; 105(31): 10913 - 10918. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Humphreys, D. Xu, M. R. Hepworth, F. Y. Liew, and R. K. Grencis IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes J. Immunol., February 15, 2008; 180(4): 2443 - 2449. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |